The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anil Jain
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anil Champalal Jain, Managing Director and member of the Promoter Group of Bajaj Healthcare, acquired 3,000 equity shares through the open market on 13th March 2026. His voting shareholding rose marginally from 4.63% to 4.64% of the company's paid-up capital, with his total holding (including convertible instruments) moving from 6.07% to 6.08%. The shares were bought on both BSE and NSE listed platforms, and the disclosure was filed under Regulation 29(1) of the SEBI Takeover Regulations, 2011. The acquisition is very small in both absolute and percentage terms, representing just 0.0095% of the total equity share capital. Bajaj Healthcare's total equity capital remained unchanged at 3,15,83,252 shares.
This is a minor open-market purchase by a promoter group member and Managing Director, which signals insider confidence in the company. Given the tiny size of the transaction, it is unlikely to materially move the stock price but reinforces promoter conviction in the business.